ASTERIAS BIOTHERAPEUTICS INC COM SER A's ticker is and the CUSIP is 025085846. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC COM SER A in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $30,000 | -45.5% | 7 | -69.6% | 0.00% | – |
| Q2 2016 | $55,000 | -49.5% | 23 | 0.0% | 0.00% | – |
| Q1 2016 | $109,000 | +21.1% | 23 | 0.0% | 0.00% | – |
| Q4 2015 | $90,000 | +1.1% | 23 | 0.0% | 0.00% | – |
| Q3 2015 | $89,000 | -16.0% | 23 | 0.0% | 0.00% | – |
| Q2 2015 | $106,000 | -53.7% | 23 | -32.4% | 0.00% | – |
| Q1 2015 | $229,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q1 2014 | $229,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CT Financial Advisors LLC | 23 | $55,000 | 0.00% |